PNC FINANCIAL SERVICES GROUP, INC. - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 213 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$113,456
-18.0%
2,467
+2.5%
0.00%
Q2 2023$138,389
+61.9%
2,408
+5.6%
0.00%
Q1 2023$85,502
+28.4%
2,280
-4.0%
0.00%
Q4 2022$66,575
-16.8%
2,376
-17.0%
0.00%
Q3 2022$80,000
+14.3%
2,863
+41.6%
0.00%
Q2 2022$70,000
-4.1%
2,022
+0.2%
0.00%
Q1 2022$73,000
+65.9%
2,017
+4.2%
0.00%
Q4 2021$44,000
+7.3%
1,936
-10.0%
0.00%
Q3 2021$41,000
-12.8%
2,151
-5.9%
0.00%
Q2 2021$47,000
-4.1%
2,287
-16.0%
0.00%
Q1 2021$49,000
+2.1%
2,721
+16.1%
0.00%
Q4 2020$48,000
+20.0%
2,344
+13.1%
0.00%
Q3 2020$40,000
-9.1%
2,073
+5.1%
0.00%
Q2 2020$44,000
+46.7%
1,972
-2.4%
0.00%
Q1 2020$30,000
-42.3%
2,021
-25.8%
0.00%
Q4 2019$52,000
+8.3%
2,725
+13.1%
0.00%
Q3 2019$48,000
-4.0%
2,409
+4.2%
0.00%
Q2 2019$50,000
+11.1%
2,313
+2.3%
0.00%
Q1 2019$45,000
+7.1%
2,262
+3.8%
0.00%
Q4 2018$42,000
+23.5%
2,180
+22.1%
0.00%
Q3 2018$34,000
+161.5%
1,785
+142.9%
0.00%
Q2 2018$13,000
-50.0%
735
-47.5%
0.00%
Q1 2018$26,000
-3.7%
1,399
-1.6%
0.00%
Q4 2017$27,000
+285.7%
1,422
+260.9%
0.00%
Q3 2017$7,000
-99.4%
394
-99.3%
0.00%
-100.0%
Q2 2017$1,082,000
+23.0%
60,521
-0.1%
0.00%0.0%
Q1 2017$880,000
-58.4%
60,611
-47.3%
0.00%
-50.0%
Q4 2016$2,117,000
-4.9%
114,970
-2.1%
0.00%
-33.3%
Q3 2016$2,226,000
+111200.0%
117,392
+112776.9%
0.00%
Q2 2016$2,000
+100.0%
104
-3.7%
0.00%
Q1 2016$1,0000.0%108
+3.8%
0.00%
Q4 2015$1,0000.0%1040.0%0.00%
Q3 2015$1,000
-50.0%
104
+3.0%
0.00%
Q2 2015$2,0001010.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$4,884,3754.79%
SHAKER INVESTMENTS LLC/OH 82,253$3,084,4881.72%
Mesirow Institutional Investment Management, Inc. 325,669$12,212,5881.33%
Portolan Capital Management 340,593$12,772,2381.22%
OBERWEIS ASSET MANAGEMENT INC/ 178,200$6,682,5001.04%
Granite Investment Partners, LLC 536,821$20,130,7880.84%
Capital Impact Advisors, LLC 15,304$573,9000.70%
Hillsdale Investment Management Inc. 155,038$5,813,9260.50%
GLOBEFLEX CAPITAL L P 89,192$3,344,7000.41%
Jackson Creek Investment Advisors LLC 25,877$9700.41%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders